When I first explained bioengineering to my husband, he asked me to make him a miniature winged bison. He’s asked for one for years, even though my work has nothing to do with making new breeds of bison. And, oh yeah, it’s impossible. But as my husband would say: that’s quitter’s talk. What good is a degree in bioengineering if it can’t be used to cook up cute little creatures?
A miniature winged bison is an example of a chimera, a mythical beast that’s a mix of two species. Like a griffin or a pegasus. In fact, wings are pretty common among chimera. Because how do you make a lion more bad-ass? Add wings.
Pure fantasy, right? Not entirely. Science has a way of making fantasy into reality. And the story of real chimeras begins with today’s gene of interest: insulin (INS).
Insulin is a hormone that regulates blood glucose levels. When blood glucose levels are too high (i.e. after a meal) insulin stimulates storage of glucose in the liver and muscle tissue so that it can be used later. We know it’s an incredibly important protein because it’s highly conserved across different species, meaning human insulin is nearly identical to that of cows, pigs, even fish [1]. In fact, pig insulin varies from human insulin by only one amino acid. In evolution, useful proteins hardly change, even while the organism evolves around it.
A type of venomous sea snail uses this similarity to hunt fish [2]. Insulin toxin in the snail venom mimics fish insulin. Once injected, the insulin toxin lowers blood glucose levels in the fish, making it sluggish (Snail. Slug-ish. See what I did there?).
This similarity also makes treating diabetes mellitus with insulin injection much easier. In the old days, insulin was harvested from animal sources [1]. Take the pancreas of a cow, a pig, or a fish, grind it up, extract the insulin, and inject. This worked ok, except for the odd allergic reaction caused by left over bits of animal pancreas in the injection.
What we needed was a source of easily-purified human insulin to replace animal-derived insulin. And the answer was bacteria! Well, bacteria and recombinant DNA technology.
In addition to their main store of DNA, bacteria have small loops of DNA called plasmids. Each plasmid contains the DNA for at least one gene. Scientists pasted the gene for human insulin (INS) into a plasmid and inserted it into bacteria [3]. Because DNA works the same way regardless of species, these bacteria read the gene as if it were bacterial DNA and produced human insulin. They became tiny insulin producing factories. Human-bacteria hybrids. Chimeras!
Today all insulin used in the US is made by recombinant DNA technology [4]. And this technique has been used to create other chimeras, or genetically modified organisms (GMO’s). Fish that glow in the dark from the fluorescent gene of a jellyfish [5]. Corn that produces an insecticide from a bacterial gene [6]. This technology gives us the power to mold the evolution to serve our needs and our fancies. Kind of a scary thought.
We’re still a long way off from ‘improving’ animals by adding wings, but the more we learn about genetic engineering, theoretically, the more complex Franken-creatures we can create. I guess that means I should get to work on that bison.
References
[1] Insulin-www.idf.org
[2] “Deadly sea snail uses weaponised insulin to make its prey sluggish”. The Guardian. 19 January 2015.
[3] Watson, James D. (2007). Recombinant DNA: Genes and Genomes: A Short Course. San Francisco: W.H. Freeman. ISBN 0-7167-2866-4.
[4] “Why is US Insulin So Expensive?”. NPR. 1 April 2015.
[5] Glofish web page
[6] Mendelsohn, M.; Kough, J.; Vaituzis, Z.; Matthews, K. (2003). “Are Bt crops safe?”. Nature Biotechnology 21 (9): 1003–1009. PMID 12949561.